JP2015522534A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522534A5
JP2015522534A5 JP2015511680A JP2015511680A JP2015522534A5 JP 2015522534 A5 JP2015522534 A5 JP 2015522534A5 JP 2015511680 A JP2015511680 A JP 2015511680A JP 2015511680 A JP2015511680 A JP 2015511680A JP 2015522534 A5 JP2015522534 A5 JP 2015522534A5
Authority
JP
Japan
Prior art keywords
nimodipine
microparticle
delivery system
polymorph form
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015511680A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015522534A (ja
JP6338573B2 (ja
Filing date
Publication date
Priority claimed from US13/800,480 external-priority patent/US9399019B2/en
Application filed filed Critical
Publication of JP2015522534A publication Critical patent/JP2015522534A/ja
Publication of JP2015522534A5 publication Critical patent/JP2015522534A5/ja
Application granted granted Critical
Publication of JP6338573B2 publication Critical patent/JP6338573B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015511680A 2012-05-09 2013-05-09 多形体組成物、その製造方法及びその使用 Expired - Fee Related JP6338573B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261644523P 2012-05-09 2012-05-09
US61/644,523 2012-05-09
US13/800,480 US9399019B2 (en) 2012-05-09 2013-03-13 Polymorph compositions, methods of making, and uses thereof
US13/800,480 2013-03-13
PCT/US2013/040265 WO2013169979A2 (en) 2012-05-09 2013-05-09 Polymorph compositions, methods of making, and uses thereof

Publications (3)

Publication Number Publication Date
JP2015522534A JP2015522534A (ja) 2015-08-06
JP2015522534A5 true JP2015522534A5 (cg-RX-API-DMAC7.html) 2016-04-21
JP6338573B2 JP6338573B2 (ja) 2018-06-06

Family

ID=49548793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015511680A Expired - Fee Related JP6338573B2 (ja) 2012-05-09 2013-05-09 多形体組成物、その製造方法及びその使用

Country Status (15)

Country Link
US (2) US9399019B2 (cg-RX-API-DMAC7.html)
EP (1) EP2846775A4 (cg-RX-API-DMAC7.html)
JP (1) JP6338573B2 (cg-RX-API-DMAC7.html)
KR (1) KR101784260B1 (cg-RX-API-DMAC7.html)
CN (1) CN104955445A (cg-RX-API-DMAC7.html)
AU (1) AU2013259476B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014027965A2 (cg-RX-API-DMAC7.html)
CA (2) CA2961123A1 (cg-RX-API-DMAC7.html)
GB (1) GB2517096A (cg-RX-API-DMAC7.html)
HK (2) HK1202264A1 (cg-RX-API-DMAC7.html)
IL (1) IL235262A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ629727A (cg-RX-API-DMAC7.html)
RU (1) RU2014149362A (cg-RX-API-DMAC7.html)
SG (1) SG11201407266PA (cg-RX-API-DMAC7.html)
WO (1) WO2013169979A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10092524B2 (en) * 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
US9399019B2 (en) * 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
JP2018522942A (ja) * 2015-05-29 2018-08-16 エッジ セラピューティクス インコーポレイテッド 視力障害を低減するための組成物及び方法
WO2017176914A1 (en) * 2016-04-07 2017-10-12 Edge Therapeutics, Inc. Formulations of site-specific, microparticulate compositions and their use to improve outcome after aneurysmal subarachnoid hemorrhage
CN105944152B (zh) * 2016-06-13 2019-02-12 龙岩紫荆创新研究院 可吸收防粘医用膜的制备方法
US20180098977A1 (en) * 2016-08-23 2018-04-12 Edge Therapeutics, Inc. Scalable microparticulate formulations containing polymorphic nimodipine form 2 prepared by a solvent evaporation process
WO2019018306A1 (en) * 2017-07-17 2019-01-24 Edge Therapeutics, Inc. ADVANCED MICROPARTICULAR FORMULATIONS CONTAINING FORM 2 OF MICRONIZED POLYMORPHIC NIMODIPINE
CN112912066B (zh) * 2018-09-08 2022-03-29 江苏九旭药业有限公司 一种尼莫地平注射液组合物及其制备方法
JP7264411B2 (ja) 2018-10-04 2023-04-25 ファルダノフ アレクサンドラ ポリ塩化ビニルフリーの親油性ポリマーベースの芳香性プラスチゾル
KR102181231B1 (ko) * 2018-11-22 2020-11-20 주식회사 메디포럼제약 로티고틴 함유 고분자 미립자의 제조방법

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3932645A (en) 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
WO1990013361A1 (en) * 1989-05-04 1990-11-15 Southern Research Institute Improved encapsulation process and products therefrom
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
DE4130173A1 (de) 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
IT1255792B (it) 1992-08-05 1995-11-16 Bayer Italia Spa Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
US5399665A (en) 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
CA2180526A1 (en) 1994-01-05 1995-07-13 Joseph C. Hogan, Jr. Method of identifying chemical compounds having selected properties for a particular application
US5712171A (en) 1995-01-20 1998-01-27 Arqule, Inc. Method of generating a plurality of chemical compounds in a spatially arranged array
US5968542A (en) 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
JP2909418B2 (ja) 1995-09-18 1999-06-23 株式会社資生堂 薬物の遅延放出型マイクロスフイア
PL189698B1 (pl) 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
KR100236771B1 (ko) 1997-04-01 2000-02-01 성재갑 히아루론산을 이용한 약물의 서방성 미세입자 제형
CA2296056A1 (en) 1997-07-10 1999-01-21 Keith Baker Methods for universally distributing therapeutic agents to the brain
US6224794B1 (en) 1998-05-06 2001-05-01 Angiotech Pharmaceuticals, Inc. Methods for microsphere production
US6455526B1 (en) * 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
US6869551B2 (en) * 2001-03-30 2005-03-22 Picoliter Inc. Precipitation of solid particles from droplets formed using focused acoustic energy
US20040235801A1 (en) 2001-10-25 2004-11-25 Jean-Pierre Julien Therapy for stroke
US20070207211A1 (en) 2003-04-10 2007-09-06 Pr Pharmaceuticals, Inc. Emulsion-based microparticles and methods for the production thereof
WO2005003180A2 (en) * 2003-04-10 2005-01-13 Pr Pharmaceuticals A method for the production of emulsion-based micro particles
JP2007526217A (ja) * 2003-06-04 2007-09-13 アルカーメス,インコーポレイテッド ナルトレキソンの多型形態
AU2004259209A1 (en) 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
US20060205733A1 (en) 2004-08-26 2006-09-14 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
WO2006084005A2 (en) 2005-02-02 2006-08-10 University Of Vermont And State Agricultural College Emergence of a r-type ca2+channel(cav2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage
US20060217340A1 (en) 2005-03-23 2006-09-28 University Of Vermont And State Agricultural College Methods and products for treating hypertension by modulation of TRPC3 channel activity
CN101045054A (zh) 2006-03-29 2007-10-03 上海医药工业研究院 尼莫地平纳米混悬剂冻干组合物、其制备方法及应用
JP2010526053A (ja) 2007-05-01 2010-07-29 シグモイド・ファーマ・リミテッド ニモジピン医薬組成物
US8252302B2 (en) 2007-06-11 2012-08-28 Edge Therapeutics, Inc. Methods and compositions to treat hemorrhagic conditions of the brain
NZ599430A (en) 2007-06-11 2014-03-28 Loch Macdonald R A drug delivery system for the prevention of cerebral vasospasm
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US20100008968A1 (en) 2008-06-26 2010-01-14 Lampe John W Method for treating cardiovascular diseases using rho kinase inhibitor compounds
EP2331082B1 (en) * 2008-09-11 2021-01-06 Evonik Corporation Solvent extraction microencapsulation with tunable extraction rates
CA2737484C (en) 2008-09-18 2017-10-10 Surmodics Pharmaceuticals, Inc. Microencapsulation process with solvent and salt
CN101416963A (zh) 2008-12-02 2009-04-29 沈阳万爱普利德医药科技有限公司 注射用尼莫地平冻干亚微乳剂及其制备方法
US20130059008A1 (en) 2009-01-23 2013-03-07 Jeffrey L. Atkinson Drying methods for tuning microparticle properties
US20100189763A1 (en) 2009-01-23 2010-07-29 Heather Nettles Controlled release systems from polymer blends
JP2012515837A (ja) 2009-01-23 2012-07-12 サーモディクス ファーマシューティカルズ, インコーポレイテッド 異なる非反復単位を有するポリマーを含むポリマー混合物、ならびにそれを作製および使用するための方法
CN101485632B (zh) 2009-02-11 2011-05-18 西安德天药业股份有限公司 尼莫地平脂质微球注射液及其制备方法
US20100291027A1 (en) 2009-05-14 2010-11-18 Jason Campbell Hyaluronic acid (ha) injection vehicle
JP5791629B2 (ja) 2009-12-22 2015-10-07 エボニック コーポレイションEvonik Corporation 微粒子を調製する乳剤基調プロセス、及び、プロセスで利用されるワークヘッド構造体
JP2013523752A (ja) 2010-03-29 2013-06-17 エボニック デグサ コーポレイション 局所投与部位における医薬組成物の保持改善のための組成物および方法
ES2646720T3 (es) 2011-02-11 2017-12-15 Edge Therapeutics, Inc. Composiciones y métodos para mejorar el pronóstico de un humano con hemorragia subaracnoidea
AU2012240131B2 (en) 2011-04-05 2017-07-20 Edge Therapeutics Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
CN102274176B (zh) 2011-08-04 2013-11-20 上海天氏利医药科技有限公司 一种尼莫地平注射液的组合物及其制备方法与应用
US9399019B2 (en) * 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof

Similar Documents

Publication Publication Date Title
RU2014149362A (ru) Полиморфные композиции, способы их получения и применение
JP5923493B2 (ja) 注射可能なデポー組成物の調製方法
US6482440B2 (en) Long acting antidepressant microparticles
JP5882993B2 (ja) 抗精神病薬デポ型注射用組成物
TWI624262B (zh) 醫藥配方
JP2014515744A5 (cg-RX-API-DMAC7.html)
JP6722828B2 (ja) フィナステリドを含むマイクロ粒子及びその製造方法
Rahmani et al. The recent insight in the release of anticancer drug loaded into PLGA microspheres
CN109414401B (zh) 用于胃肠外给药的生物可降解聚合物微球组合物
WO2008086756A1 (en) Developable biodegradable microspheric blood vessel embolism materials
JP2023506175A (ja) カリプラジン放出製剤
WO2018108164A1 (zh) 一种硼替佐米药物组合物及其应用
EA018203B1 (ru) Композиция пролонгированного высвобождения, содержащая памоат пасиреотида в микрочастицах с полимерной матрицей, способ получения микрочастиц и способ лечения
CN113797160A (zh) 一种盐酸米诺环素纳米缓释凝胶及其制备方法和应用
CN117858698A (zh) 一种微球悬液、微粒制剂及其制备方法
WO2024240116A1 (zh) 一种注射用药物缓释微球及其制备方法
CN102988301A (zh) 一种含贝伐单抗的长效缓释微球的制备方法
CN117530933A (zh) 一种吡仑帕奈长效缓释微球、制备方法及缓释注射剂
JPWO2007102447A1 (ja) 付着型マイクロカプセル
JP4879488B2 (ja) テモゾロマイドを含む放出制御システム
CN106580915B (zh) 一种载利福喷丁和利奈唑胺的缓释微球及其制备方法和用途
US20260000683A1 (en) Sustained-release injectable composition containing dutasteride
CN100464736C (zh) 同载抗代谢药物及其增效剂的抗癌缓释注射剂
CN108113976B (zh) Th-302制剂、制备方法及其用途
WO2024037536A1 (zh) 包含伐尼克兰的缓释制剂及其制备方法